Monday, November 21, 2022 3:06:58 PM
I have had Twitter PM conversations with AF in the past. He is convinced NWBO analyzed the data post hoc after learning OS would be a better endpoint and PFS failed. He thinks NWBO draw the bull's eye after it threw the darts.
As I told ex I told AF that the FDA permits biotech to change endpoints and to amend their SAP prior to data lock of their medical trial. He believes NWBO changed endpoints just after TLD was presented on May 10, with the changing of clinicaltrials.gov after May 10 as evidence. I told him that clinicaltrials.gov can be changed by the biotech whenever they wish, the website is independent of (amended) SAP submission with the FDA. I send him a screenshot of the EMA website where the changed endpoints showed up at the beginning of Oct 2020 making his dart-throwing argument mute. But he wont have any of it and is lying on purpose.
I will never communicate with these awful horrible excuse of a men again.
He should be sued IMO by NWBO
As I told ex I told AF that the FDA permits biotech to change endpoints and to amend their SAP prior to data lock of their medical trial. He believes NWBO changed endpoints just after TLD was presented on May 10, with the changing of clinicaltrials.gov after May 10 as evidence. I told him that clinicaltrials.gov can be changed by the biotech whenever they wish, the website is independent of (amended) SAP submission with the FDA. I send him a screenshot of the EMA website where the changed endpoints showed up at the beginning of Oct 2020 making his dart-throwing argument mute. But he wont have any of it and is lying on purpose.
I will never communicate with these awful horrible excuse of a men again.
He should be sued IMO by NWBO
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
